WMT

119.39

+0.62%↑

COST

982.49

+1.97%↑

TGT

106.08

-2.84%↓

KR

63.84

+1.12%↑

DG.US

147.07

+0.49%↑

WMT

119.39

+0.62%↑

COST

982.49

+1.97%↑

TGT

106.08

-2.84%↓

KR

63.84

+1.12%↑

DG.US

147.07

+0.49%↑

WMT

119.39

+0.62%↑

COST

982.49

+1.97%↑

TGT

106.08

-2.84%↓

KR

63.84

+1.12%↑

DG.US

147.07

+0.49%↑

WMT

119.39

+0.62%↑

COST

982.49

+1.97%↑

TGT

106.08

-2.84%↓

KR

63.84

+1.12%↑

DG.US

147.07

+0.49%↑

WMT

119.39

+0.62%↑

COST

982.49

+1.97%↑

TGT

106.08

-2.84%↓

KR

63.84

+1.12%↑

DG.US

147.07

+0.49%↑

Search

Hims & Hers Health Inc

Fermé

SecteurConsommation de base

28.85 -5.16

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.95

Max

30.47

Chiffres clés

By Trading Economics

Revenu

-27M

16M

Ventes

54M

599M

P/E

Moyenne du Secteur

59.208

29.272

Marge bénéficiaire

2.633

Employés

1,637

EBITDA

-7.3M

30M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+40.73% upside

Dividendes

By Dow Jones

Prochains Résultats

23 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.9B

7.1B

Ouverture précédente

34.01

Clôture précédente

28.85

Sentiment de l'Actualité

By Acuity

50%

50%

66 / 140 Classement par Consumer defensive

Score Technique

By Trading Central

Confiance

Bullish Evidence

Hims & Hers Health Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 août 2025, 00:05 UTC

Actions en Tendance

Stocks to Watch: Palantir Technologies, Hims & Hers Health, Vertex Pharmaceuticals, Kyndryl

29 avr. 2025, 12:54 UTC

Principaux Mouvements du Marché

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

4 avr. 2025, 22:38 UTC

Actions en Tendance

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 avr. 2025, 23:15 UTC

Principaux Mouvements du Marché

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 févr. 2025, 15:33 UTC

Principaux Mouvements du Marché

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

2 nov. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk -- Heard on the Street -- WSJ

22 oct. 2025, 21:25 UTC

Résultats

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

5 août 2025, 20:44 UTC

Résultats

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 18:17 UTC

Résultats

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 17:26 UTC

Résultats
Acquisitions, Fusions, Rachats

Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem. -- Barrons.com

5 août 2025, 15:25 UTC

Résultats

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 août 2025, 11:27 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:55 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:36 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

29 juil. 2025, 16:55 UTC

Résultats

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%. -- Barrons.com

24 juin 2025, 10:26 UTC

Market Talk

Novo Nordisk Sends Clear Message on Copycat Drugs -- Market Talk

3 juin 2025, 15:03 UTC

Acquisitions, Fusions, Rachats

Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com

7 mai 2025, 13:56 UTC

Résultats

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

6 mai 2025, 14:24 UTC

Résultats

Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low. -- Barrons.com

30 avr. 2025, 09:30 UTC

Actualités

Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ

2 avr. 2025, 16:53 UTC

Actualités

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mars 2025, 15:54 UTC

Actualités

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 févr. 2025, 23:20 UTC

Résultats

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 févr. 2025, 12:00 UTC

Actualités

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

Comparaison

Variation de prix

Hims & Hers Health Inc prévision

Objectif de Prix

By TipRanks

40.73% hausse

Prévisions sur 12 Mois

Moyen 42.88 USD  40.73%

Haut 85 USD

Bas 29 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

11 ratings

2

Achat

6

Maintien

3

Vente

Score Technique

By Trading Central

36.685 / 52.35Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

66 / 140Classement par Consommation de base

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
help-icon Live chat